Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001396093-08-000002
Filing Date
2008-01-31
Accepted
2008-01-31 12:45:00
Documents
1
Period of Report
2007-12-29

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 5  
1 PRIMARY DOCUMENT edgar.xml 5 4934
  Complete submission text file 0001396093-08-000002.txt   7034
Mailing Address 5800 PARK OF COMMERCE BLVD NW STE 322 BOCA RATON FL 33487
Business Address 5800 PARK OF COMMERCE BLVD N W STE 322 BOCA RATON FL 33487 5619895800
NABI BIOPHARMACEUTICALS (Issuer) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1225
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O NABI BIOPHARMACEUTICALS 5800 PARK OF COMMERCE BLVD., N.W. BOCA RATON FL 33487
Business Address 561-989-5800
Siegel Jordan I (Reporting) CIK: 0001365339 (see all company filings)

Type: 5 | Act: 34 | File No.: 000-04829 | Film No.: 08563508